Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. (Q49016618)

17 February 2018

title

Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells. (English)

1 reference

17 February 2018

1 reference

Na Wang

1

1 reference

17 February 2018

Yan Wang

2

1 reference

17 February 2018

Guohua Yu

3

1 reference

17 February 2018

Chonggang Yuan

4

1 reference

17 February 2018

Jiyan Ma

5

1 reference

17 February 2018

publication date

22 July 2011

1 reference

17 February 2018

published in

Neurochemical Research

1 reference

17 February 2018

volume

36

1 reference

17 February 2018

issue

11

1 reference

17 February 2018

page(s)

2169-2175

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s11064-011-0541-z

exact match

0 references

cites work

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Altered vesicular dopamine storage in Parkinson's disease: a premature demise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Intraneuronal dopamine-quinone synthesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Role of quinones in toxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Dopamine covalently modifies and functionally inactivates parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Iron, the substantia nigra and related neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Vulnerability to DNA damage in the aging rat substantia nigra: a study with the comet assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Toxic effects of dopamine metabolism in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Approaches to prevent dopamine quinone-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-011-0541-Z

Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the l-dopa

21 January 2018

1 reference

12 December 2020

Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. Multiple-site phosphorylation in vivo and in synaptosomes

1 reference

12 December 2020

Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species.

1 reference

12 December 2020

Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death

1 reference

12 December 2020

Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

1 reference

12 December 2020

Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Specific detection of quinoproteins by redox-cycling staining

1 reference

12 December 2020

L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein

1 reference

12 December 2020

10.1007/S11064-011-0541-Z

Identifiers

DOI

1 reference

17 February 2018

Dimensions Publication ID

0 references

1 reference

17 February 2018